Structure Therapeutics Inc. — Director's Dealing 2023

Feb 3, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2023-02-02

Reporting Person: Yoon Jun (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	1063664	Direct
Ordinary Shares	1554586	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock option (right to buy)	$0.39	2030-01-21	Ordinary Shares (100000)		Direct
Stock option (right to buy)	$1.21	2031-09-22	Ordinary Shares (100000)		Direct

Footnotes

F1: By Jun Sik Yoon and Hayung Yang Yoon, Trustees of The Yoon Family Trust, dated December 11, 2019.

F2: 1/4th of the shares vested one year after May 1, 2019 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.

F3: The shares shall vest in a series of 48 successive equal monthly installments beginning one month after September 16, 2021.